Humedix Co., Ltd. (KOSDAQ:200670)

South Korea flag South Korea · Delayed Price · Currency is KRW
50,500
-700 (-1.37%)
Oct 10, 2025, 3:30 PM KST
-1.37%
Market Cap521.17B
Revenue (ttm)110.99B
Net Income (ttm)9.06B
Shares Out10.32M
EPS (ttm)963.99
PE Ratio52.39
Forward PE11.57
Dividend660.00 (1.29%)
Ex-Dividend DateAug 20, 2025
Volume162,810
Average Volume274,555
Open51,300
Previous Close51,200
Day's Range49,250 - 51,300
52-Week Range25,400 - 77,200
Beta0.41
RSI31.38
Earnings DateNov 10, 2025

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Sector Healthcare
Founded 2002
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 200670
Full Company Profile

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.

Financial Statements

News

There is no news available yet.